These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 32963468)

  • 1. Scottish Medicines Consortium September 2020 decisions.
    PharmacoEcon Outcomes News; 2020; 862(1):36. PubMed ID: 32963468
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes.
    Morrell L; Wordsworth S; Fu H; Rees S; Barker R
    BMC Health Serv Res; 2017 Aug; 17(1):613. PubMed ID: 28854927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK rationing of new medicines. NICE should follow example of Scottish Medicines Consortium.
    Cornell SJ
    BMJ; 2009 Feb; 338():b634. PubMed ID: 19223346
    [No Abstract]   [Full Text] [Related]  

  • 4. Equity and efficiency: striving for a solution for the introduction of new medicines.
    Hems S; Black C; McIver L; Bennie M
    Scott Med J; 2012 Nov; 57(4):191-5. PubMed ID: 23138577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared.
    Cairns J
    Health Policy; 2006 Apr; 76(2):134-43. PubMed ID: 15982779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Cetuximab in 1st-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer in Scotland: A Summary of the Submission to the Scottish Medicines Consortium.
    Jarrett J; Ovcinnikova O; Hnoosh A; Harty G; Byrne B; von Hohnhorst P
    Value Health; 2014 Nov; 17(7):A638. PubMed ID: 27202280
    [No Abstract]   [Full Text] [Related]  

  • 7. Scottish Medicines Consortium: an overview of rapid new drug assessment in Scotland.
    Dear J; O'Dowd C; Timoney A; Paterson KR; Walker A; Webb DJ
    Scott Med J; 2007 Aug; 52(3):20-6. PubMed ID: 17874711
    [No Abstract]   [Full Text] [Related]  

  • 8. Scottish Medicines Consortium.
    Kohli HS
    Natl Med J India; 2005; 18(3):162. PubMed ID: 16130621
    [No Abstract]   [Full Text] [Related]  

  • 9. Scotland v England deal on prescribed drugs: Scottish Medicines Consortium responds.
    Webb DJ; Paterson KR; Timoney A; Walker A
    BMJ; 2006 Nov; 333(7577):1073; author reply 1073. PubMed ID: 17110734
    [No Abstract]   [Full Text] [Related]  

  • 10. New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.
    Varnava A; Bracchi R; Samuels K; Hughes DA; Routledge PA
    Pharmacoeconomics; 2018 May; 36(5):613-624. PubMed ID: 29520603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scottish consortium for development and education in dental primary care.
    Clarkson JE; Murray M; Pitts NB; MacFarlane TW; Newton JP; Burke FJ; Bain CA; Ibbetson R; Rennie JS
    Br Dent J; 2000 Aug; 189(4):222-3. PubMed ID: 11036751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A guide to health economic evaluations.
    Drug Ther Bull; 2010 Sep; 48(9):105-8. PubMed ID: 20810710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement of targeted cancer therapies within 3 different European health care systems.
    Mihajlović J; Dolk C; Tolley K; Simoens S; Postma MJ
    Clin Ther; 2015 Feb; 37(2):474-80. PubMed ID: 25638534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
    Mason A; Drummond M; Ramsey S; Campbell J; Raisch D
    J Clin Oncol; 2010 Jul; 28(20):3234-8. PubMed ID: 20498408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme.
    Nathwani D; Sneddon J; Malcolm W; Wiuff C; Patton A; Hurding S; Eastaway A; Seaton RA; Watson E; Gillies E; Davey P; Bennie M;
    Int J Antimicrob Agents; 2011 Jul; 38(1):16-26. PubMed ID: 21515030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional survey of the access of older people in the Scottish Highlands to general medical practices, community pharmacies and prescription medicines.
    Rushworth GF; Cunningham S; Pfleger S; Hall J; Stewart D
    Res Social Adm Pharm; 2018 Jan; 14(1):76-85. PubMed ID: 28159532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia.
    Fischer KE; Heisser T; Stargardt T
    Health Policy; 2016 Oct; 120(10):1115-1122. PubMed ID: 27628196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug assessment: UK style.
    Drug Ther Bull; 2013 Dec; 51(12):141-4. PubMed ID: 24336496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study of the relationship between the Scottish Medicines Consortium and their clinical experts.
    Newham R; Corcoran ED; Dear JW; Hems S; McTaggart S; Bennie M
    J Eval Clin Pract; 2016 Jun; 22(3):311-8. PubMed ID: 25809529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.